Literature DB >> 2009756

Effects of indomethacin on hepatogenic pulmonary angiodysplasia.

H Shijo1, H Sasaki, K Yuh, S Sakaguchi, M Okumura.   

Abstract

A patient had liver cirrhosis associated with marked hypoxemia. With administration of indomethacin (75 mg/day for six days), PaO2 was elevated up to 50 mm Hg from 44 mm Hg. At that time, dynamic pulmonary perfusion imaging revealed a plateau time course curve of MAA uptake in the lungs, as compared with findings obtained during the state of severe hypoxemia without indomethacin. These observations suggest that part of hepatogenic pulmonary angiodysplasia is a functional vasodilatation that is presumably modulated by vasoactive substances, such as prostaglandins and/or other eicosanoids.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2009756     DOI: 10.1378/chest.99.4.1027

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

Review 1.  Hepatopulmonary syndrome: What we know and what we would like to know.

Authors:  Israel Grilo-Bensusan; Juan Manuel Pascasio-Acevedo
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  The role of garlic in hepatopulmonary syndrome: a randomized controlled trial.

Authors:  Binay K De; Deep Dutta; Subrata K Pal; Subhabrata Gangopadhyay; Sumanta Das Baksi; Adyapad Pani
Journal:  Can J Gastroenterol       Date:  2010-03       Impact factor: 3.522

3.  Comparison of analgesic effect of locally and systemically administered ketorolac in mastectomy patients.

Authors:  V Bosek; C E Cox
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

4.  Primary biliary cirrhosis complicated by severe hypoxemia.

Authors:  S Shiomi; T Kuroki; S Fujimoto; M Yamaoka; H Sakaguchi; T Takeda; S Nishiguchi; S Nakajima; K Kobayashi; H Ochi
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

5.  Hepatopulmonary Syndrome and Portopulmonary Hypertension.

Authors:  Michael J. Krowka
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-06

6.  Reversibility of hepatopulmonary syndrome evidenced by serial pulmonary perfusion scan.

Authors:  H Shijo; H Sasaki; H Sakata; H Kusuhara; T Ueki; M Okumura
Journal:  Gastroenterol Jpn       Date:  1993-02

7.  Hepatopulmonary Syndrome and Portopulmonary Hypertension.

Authors:  Michael J. Krowka
Journal:  Curr Treat Options Gastroenterol       Date:  2001-12

8.  Intrapulmonary shunting in the biliary atresia/polysplenia syndrome: reversal after liver transplantation.

Authors:  M S Fewtrell; G Noble-Jamieson; S Revell; J Valente; P Friend; P Johnston; A Rasmussen; N Jamieson; R Y Calne; N D Barnes
Journal:  Arch Dis Child       Date:  1994-06       Impact factor: 3.791

Review 9.  Review article: Update on current and emergent data on hepatopulmonary syndrome.

Authors:  Stergios Soulaidopoulos; Evangelos Cholongitas; George Giannakoulas; Maria Vlachou; Ioannis Goulis
Journal:  World J Gastroenterol       Date:  2018-03-28       Impact factor: 5.742

Review 10.  Current concepts in the management of hepatopulmonary syndrome.

Authors:  Vincent Ho
Journal:  Vasc Health Risk Manag       Date:  2008
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.